A Long-term Safety Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes

NCT06010004 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

466

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Orforglipron

Sponsor

Eli Lilly and Company